The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

被引:45
作者
Cohen, Allison L. [1 ,2 ]
Wenger, Julia B. [3 ]
James-Todd, Tamarra [4 ]
Lamparello, Brooke M. [1 ]
Halprin, Elizabeth [1 ,2 ]
Serdy, Shanti [1 ,2 ]
Fan, Shuling [2 ]
Horowitz, Gary L. [2 ]
Lim, Kee-Hak [2 ]
Rana, Sarosh [2 ]
Takoudes, Tamara C. [2 ]
Wyckoff, Jennifer A. [5 ]
Thadhani, Ravi [3 ]
Karumanchi, S. Ananth [2 ,6 ]
Brown, Florence M. [1 ,2 ]
机构
[1] Joslin Diabet Ctr, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[6] Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
Angiogenesis; Diabetes; HbA1C; PlGF; Preeclampsia; sFlt1; PREGNANCY-INDUCED HYPERTENSION; ADVERSE NEONATAL OUTCOMES; GLYCEMIC CONTROL; NULLIPAROUS WOMEN; TYPE-1; RETINOPATHY; MELLITUS; DISEASE; SERUM;
D O I
10.3109/10641955.2013.837175
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess whether glycemic control, soluble fms-like tyrosine kinase 1 (sFlt1) and placental growth factor (PlGF) were associated with the development of preeclampsia (PE) or gestational hypertension (GHTN) in women with preexisting diabetes. Methods: Maternal circulating angiogenic factors (sFlt1 and PlGF) measured on automated platform were studied at four time points during pregnancy in women with diabetes (N=159) and reported as multiples of the median (MOM) of sFlt1/PlGF ratio (median, 25th-75th percentile) noted in non-diabetic non-hypertensive control pregnant population (N=139). Diagnosis of PE or GHTN was determined by review of de-identified clinical data. Results: PE developed in 12% (N=19) and GHTN developed in 23% (N=37) of the women with diabetes. Among diabetic women without PE or GHTN, median sFlt1/PlGF levels at 35-40 weeks was threefold higher than in non-diabetic controls [MOM 3.21(1.19-7.24), p = 0.0001]. Diabetic women who subsequently developed PE had even greater alterations in sFlt1/PlGF ratio during the third trimester [MOM for PE at 27-34 weeks 15.18 (2.37-26.86), at 35-40 weeks 8.61(1.20-18.27), p <= 0.01 for both windows compared to non-diabetic controls]. Women with diabetes who subsequently developed GHTN also had significant alterations in angiogenic factors during third trimester; however, these findings were less striking. Among women with diabetes, glycosylated hemoglobin (HbA1c) during the first trimester was higher in subjects who subsequently developed PE (7.7 vs 6.7%, p = 0.0001 for diabetic PE vs diabetic non-PE). Conclusions: Women with diabetes had a markedly altered anti-angiogenic state late in pregnancy that was further exacerbated in subjects who developed PE. Altered angiogenic factors may be one mechanism for the increased risk of PE in this population. Increased HbA1c in the first trimester of pregnancies in women with diabetes was strongly associated with subsequent PE.
引用
收藏
页码:81 / 92
页数:12
相关论文
共 35 条
[1]  
ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159
[2]   Low-dose aspirin to prevent preeclampsia in women at high risk [J].
Caritis, S ;
Sibai, B ;
Hauth, J ;
Lindheimer, MD ;
Klebanoff, M ;
Thom, E ;
VanDorsten, P ;
Landon, M ;
Paul, R ;
Miodovnik, M ;
Meis, P ;
Thurnau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :701-705
[3]  
COMBS CA, 1993, OBSTET GYNECOL, V82, P802
[4]   Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetes [J].
Cundy, T ;
Slee, F ;
Gamble, G ;
Neale, L .
DIABETIC MEDICINE, 2002, 19 (06) :482-+
[5]   Pregnancy outcome in type 1 diabetic women with microalbuminuria [J].
Ekbom, P ;
Damm, P ;
Feldt-Rasmussen, B ;
Feldt-Rasmussen, U ;
Molvig, J ;
Mathiesen, ER .
DIABETES CARE, 2001, 24 (10) :1739-1744
[6]   PREECLAMPSIA IN DIABETIC PREGNANCIES [J].
GARNER, PR ;
DALTON, ME ;
DUDLEY, DK ;
HUARD, P ;
HARDIE, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (02) :505-508
[7]   Epidemiology of pregnancy-induced hypertension and preeclampsia in Type 1 (insulin-dependent) diabetic pregnancies in Sweden [J].
Hanson, U ;
Persson, B .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (06) :620-624
[8]   Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with Type I diabetes mellitus [J].
Hiilesmaa, V ;
Suhonen, L ;
Teramo, K .
DIABETOLOGIA, 2000, 43 (12) :1534-1539
[9]   Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial [J].
Holmes, Valerie A. ;
Young, Ian S. ;
Patterson, Christopher C. ;
Pearson, Donald W. M. ;
Walker, James D. ;
Maresh, Michael J. A. ;
McCance, David R. .
DIABETES CARE, 2011, 34 (08) :1683-1688
[10]   Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy [J].
Howarth, C. ;
Gazis, A. ;
James, D. .
DIABETIC MEDICINE, 2007, 24 (11) :1229-1234